Credits: Canva
The popular weight-loss drug Ozempic, and similar GLP=1 medications like Wegovy and Mounjaro and known for a little more than fat loss jabs. They have a more complicate side to it. This is all about the sagging breasts, surprise pregnancies to confusing cancer scans, and many more such side effects. Of course due to its consequence of helping people use weight, have these drugs gained popularity, but also because these injections are producing ripple effects fat beyond the waistline.
If 'Ozempic Face' was not enough - a term used for facial sagging after rapid weight loss, then there is a new cosmetic concern: Ozempic breasts.
Also Read: Tramadol: Is It Time To Reconsider This Go-to Drug For Treating Chronic Pain?
Women using this weekly injection have reported dropping, deflated breasts after they have shred pounds quickly. Experts have also stressed that this is not a drug-specific effect and could happen to anyone who lost a significant amount of fat in a short time.
“In the breast area, rapid fat loss can leave the skin envelope empty, causing the breasts to look deflated and the nipples facing downward,” explained Dr. Ronald F. Rosso, medical director at Peninsula Plastic Surgery in California, as reported in Healthline. “It’s very similar to what we see after more traditional weight-loss surgeries such as gastric bypass.”
Women who have experienced pregnancy and breastfeeding may be at a greater risk, said Dr Walter J Joseph, a California-based aesthetic and reconstructive surgeon. For them, less cleavage and fullness, translates into a "sad looking" breast appearance.
The best measure? Experts suggest a well-fitted bra throughout the day. "It won't reverse the change, but it can help with comfort and prevent further sagging," said Dr Elie Levine, director of Plastic Surgery & Dermatology of NYC PLLC.
Not just Ozempic Breasts, but even Ozempic Butt, a droopy backside has made it to the list. For those seeking to restore firmness and shape, procedures like butt lifting and breast lifts for Ozempic breasts are available, including mastopexy.
What happens in this surgery is doctors remove the sagging skin, reshape the tissue and reposition the nipple to face forward rather than downward. The lift can also be paired with implants for added fullness.
“Patients should wait until they reach and maintain their goal weight before considering surgery,” advised Dr. Christopher Costa, as reported in the NY Post. Dr Costa is the founder of Platinum Plastic Surgery in Las Vegas. “Your body after Ozempic may be completely different, and it’s important to give it time to stabilize before making permanent changes.”
Dr Costa also noted in a 2022 study found two-thirds users regained the lost weight within a year of stopping GLP-1 drugs. Thus timing is the key to avoid repeating costly procedures. “If you’re not ready for surgery, embrace your new look,” he added. “Buy new clothes that flatter your shape, celebrate the healthier version of you.”
Not all complaints are about sagging, some are also about sore and swollen breasts, especially in the early weeks of treatment.
"They feel bigger and tender, like the first trimester of pregnancy," shared a Reddit user. Experts suggest that it is due to the hormonal shifts that your body undergoes or due to the temporary inflammation.
What could work? Massaging, is what Dr Elie Levine recommends. This could boost circulation. Other than that, one can also use painkillers, or cool compresses for relief.
Credits: PTI
Delhi woke up to a slightly lower levels of AQI on Sunday Morning, November 30, as city's AQI dropped to 269 at 7am down from 305, which was recorded at 4pm on Saturday. This now falls under the "poor" category. However, experts say that the relief is temporary.
Many health experts and those who have studied the impact of pollution on humans have pointed out that anything above 300 is harmful to humans. These harms are not just limited to respiratory illnesses, and to lungs, causing lung cancers, but can also be the reason why obesity is on the rise.
As per a 2021 study titled Effect of Air Pollution on Obesity in Children: A systematic Review and Meta-Analysis, there is a connection between air pollution and weight gain through biological behavioral mechanism. The major pollutants causing obesity are nitrous oxides, nitrogen dioxide, ozone, and particulate matter.
These could lead to systematic inflammation and metabolic disturbances, which can lead to weight gain and obesity. The study mentions that fine particulate matter [PM2.5], when it enters our body, it influences the metabolism rates.
The 2021 study also revealed that increase in air pollution, and road traffic noise was also associated with childhood obesity.
Also Read: 'Facing Breathing Issues After Morning Walk' Says CJI Surya Kant As Delhi's Toxic Air Worsens
Another 2011 study titled The influence of air pollution on cardiovascular and pulmonary function and exercise capacity: Canadian Health Measures Survey (CHMS), found that air pollutants may indirectly impact body weight by raising the risk of chronic conditions like blood pressure, heart diseases or lung diseases. "Exposure to higher concentrations of air pollution was associated with higher resting blood pressure and lower ventilatory function. Ozone was associated with reduced exercise capacity," researchers of the study wrote.
The latest study published in 2024 titled The association between air pollution and obesity: an umbrella review of meta-analyses and systematic reviews, found that air pollution can impact metabolic function by influencing inflammation in fat tissue. It leads to an increase in oxidative stress and alters one's dietary habits.
This does not end here, air pollution could also negatively impact women. As Dr Anuradha Kapur, Principal Director (Obstetrics & Gynaecology) and Head of Unit, Max Smart Super Speciality Hospital, Saket says, "Environmental pollutants, such as pesticides and microplastics, can affect reproductive health and hormone regulation, potentially impacting menstrual cycles."
Dr Sonam Simpatwar, Gynaecologist with a diploma in reproductive medicine, practising at Central Railway Hospital, Mumbai further explained how pollutants impact women's health:
Endocrine Disruptors: Chemicals found in pollution, plastics, and pesticides can mimic or interfere with hormones, potentially affecting menstrual cycles.
Climate Change: Rising temperatures, extreme weather events, and changes in water quality can impact food production, nutrition, and overall health, which can indirectly affect menstrual health.
Stress: Environmental stressors, such as pollution and climate change, can lead to increased stress, which is known to influence menstrual cycles.
"It's important to note that these are potential factors, and more research is needed to fully understand their impact on menstrual health," she said.
Credits: Canva
High levels of low-density lipoprotein cholesterol (LDL-C), commonly called "bad" cholesterol, continue to be a leading modifiable risk factor for atherosclerotic cardiovascular disease (ASCVD) worldwide. While statins and other cholesterol-lowering medications have significantly improved treatment, many patients still do not reach the LDL-C targets recommended by guidelines.
However, a new potential solution has emerged. The experimental daily oral drug called enlicitide, part of the PCSK9 inhibitor class, demonstrated in a key Phase 3 study (CORALreef Lipids) a reduction in LDL-C of about 55.8% at 24 weeks, with post-hoc analysis suggesting reductions up to 59.7% compared to a placebo.
Statins are the standard first-line treatment for high LDL-C and have strong evidence for lowering the risk of cardiovascular events. Yet, many patients either cannot tolerate high doses or still have elevated cholesterol levels. Injectable PCSK9 inhibitors, which are monoclonal antibodies, address this gap and can lower LDL-C by up to 70% but are expensive, require injections, and have limited uptake.
Introducing an oral PCSK9 inhibitor could make powerful LDL-C reduction more accessible. According to trial data, enlicitide may achieve reductions similar to injectable options while being more convenient and potentially more widely available.
The CORALreef Lipids Phase 3 study involved 2,912 adults at risk of or with established ASCVD who were either already on lipid-lowering therapy or unable to take statins. Participants were randomly assigned to receive a daily 20 mg dose of oral enlicitide or a placebo. At 24 weeks, the main analysis showed an average LDL-C reduction of 55.8%, with a post-hoc reanalysis estimating 59.7%. The drug’s safety profile was similar to placebo, with no major safety concerns reported and low rates of discontinuation due to adverse effects.
These reductions are substantial, suggesting oral enlicitide could:
In India, where ASCVD prevalence is high and expensive therapies are less accessible, this pill could provide a practical, scalable option alongside diet, exercise, and current statin or ezetimibe treatments.
Despite the promising LDL-C reductions, several key issues remain:
The investigational oral pill enlicitide could represent a major advance in cholesterol management. For patients whose LDL-C remains high despite statins, or who cannot tolerate injections, it offers a potent and convenient alternative. Yet, medicine requires caution.
Disclaimer: This content is for general informational purposes only and is not a substitute for professional medical advice. Always consult a doctor or specialist before starting or changing any medication
Credits: Canva
According to NHS advice, people who use gabapentin may face rare emergencies linked to the medicine. Although it is not officially classed as a painkiller, doctors often prescribe it for nerve pain that follows an injury. It is also used for discomfort caused by shingles or diabetes. The medicine works by interrupting pain signals that move between the brain and spinal cord. Gabapentin is also a common treatment for epilepsy and falls under the group of anticonvulsant drugs. Most people take it as capsules, tablets, or a liquid, usually three times a day.
NHS information notes that the majority of users do not face any side effects. Those who do usually notice only mild and short-lived symptoms.
Gabapentin is a prescription drug that belongs to a group of medicines called anticonvulsants. Doctors usually give it to people who have nerve pain or to help manage certain types of seizures in epilepsy. It is sold under names like Neurontin, Gralise, and Horizant, along with widely used generic versions.
Gabapentin is prescribed for a few main purposes:
There are times when gabapentin may lead to serious reactions that need emergency attention. Mild effects can include an upset stomach, dry mouth, weight gain, or slight memory troubles.
More concerning reactions may involve thoughts of self-harm, unusual muscle pain or weakness, or seeing or hearing things that are not there. Even then, NHS guidance states that these usually require an urgent call to a doctor or 111 rather than ambulance help.
Like many medicines, gabapentin can trigger a severe allergic reaction known as anaphylaxis. This can cause several symptoms, such as swelling in the throat or difficulty breathing. The NHS advises calling 999 if you are taking gabapentin and experience any of the following:
© 2024 Bennett, Coleman & Company Limited